Abstract Objective Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive hereditary disease and is a congenital metabolic disorder of neurotransmitter biosynthesis. It is mainly manifested as hypotonia, oculogyric crisis, autonomic dysfunction, and developmental delay. This article reports a boy manifested as delayed motor development, hypotonia, and oculogyric crisis. Gene screening for metabolic disorders revealed new compound heterozygous mutations, c.1063dupA (p.I355fs) and c.250A > C (p.S84R), in the exon of DDC gene. The boy had a significant increase in 3-O-methyldopa as measured by dried blood spot. Therefore, he was diagnosed with AADC deficiency. After treatment with the dopamine receptor agonist pramipexole dihydrochloride, the catechol-O-methyltransferase inhibitor entacapone, and vitamin B6, the boy showed mild improvements in hypotonia, blepharoptosis, and oculogyric crisis. Clinical physicians should enhance their ability for identifying AADC deficiency, so as to facilitate early diagnosis and treatment of this disorder. Genetic counseling for birth health and prenatal diagnosis should be performed for parents in need.
Hyland K, Surtees RA, Rodeck C, et al. Aromatic L-amino acid decarboxylase deficiency:Clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis[J]. Neurology, 1992, 42(10):1980-1988.
[2]
Lee LK, Cheung KM, Cheng WW, et al. A rare cause of severe diarrhoea diagnosed by urine metabolic screening:aromatic L-amino acid decarboxylase deficiency[J]. Hong Kong Med J, 2014, 20(2):161-164.
[3]
Alfadhel M, Kattan R. Aromatic amino acid decarboxylase deficiency not responding to pyridoxine and bromocriptine therapy:case report and review of response to treatment[J]. J Cent Nerv Syst Dis, 2014, 6:1-5.
[4]
Brun L, Ngu LH, Keng WT, et al. Clinical and biochemical features of aromatic Lamino acid decarboxylase deficiency[J]. Neurology, 2010, 75(1):64-71.
[5]
Haliloğlu G, Vezir E, Baydar L, et al. When do we need to perform a diagnostic lumbar puncture for neurometabolic diseases? Positive yield and retrospective analysis from a tertiary center[J]. Turk J Pediatr, 2012, 54(1):52-58.
[6]
Atwal PS, Donti TR, Cardon AL, et al. Aromatic L-amino acid decarboxylase deficiency diagnosed by clinical metabolomic profiling of plasma[J]. Mol Genet Metab, 2015, 115(2-3):91-94.
[7]
Chen PW, Lee NC, Chien YH, et al. Diagnosis of aromatic L-amino acid decarboxylase deficiency by measuring 3-O-methyldopa concentrations in dried blood spots[J]. Clin Chim Acta, 2014, 431:19-22.
[8]
Chien YH, Chen PW, Lee NC, et al. 3-O-methyldopa levels in newborns:Result of newborn screening for aromatic L-amino-acid decarboxylase deficiency[J]. Mol Genet Metab, 2016, 118(4):259-263.
[9]
Montioli R, Dindo M, Giorgetti A, et al. A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency:from molecular mechanisms to therapy implications[J]. Human Molecular Genetics, 2014, 23(20):5429-5440
[10]
Manegold C, Hoffmann GF, Degen I, et al. Aromatic L-amino acid decarboxylase deficiency:clinical features, drug therapy and follow-up[J]. J Inherit Metab Dis, 2009, 32(3):371-380.
[11]
Allen GF, Land JM, Heales SJ. A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency[J]. Mol Genet Metab, 2009, 97(1):6-14.
[12]
Tay SK, Poh KS, Hyland K, et al. Unusually mild phenotype of AADC deficiency in 2 siblings[J]. Mol Genet Metab, 2007, 91(4):374-378.
[13]
Mastrangelo M, Caputi C, Galosi S, et al. Transdermal rotigotine in the treatment of aromatic L-amino acid decarboxylase deficiency[J]. Mov Disord, 2013, 28(4):556-557
Chtarto A, Bockstael O, Tshibangu T, et al. A next step in adeno-associated virus-mediated gene therapy for neurological diseases:regulation and targeting[J]. Br J Clin Pharmacol, 2013, 76(2):217-232.
[16]
Lee NC, Chien YH, Hu MH, et al. Treatment of congenital neurotransmitter deficiencies by intracerebral ventricular injection of an adeno-associated virus serotype 9 vector[J]. Hum Gene Ther, 2014, 25(3):189-198.
[17]
Kumar SR, Markusic DM, Biswas M, et al. Clinical development of gene therapy:results and lessons from recent successes[J].Mol Ther Methods Clin Dev, 2016, 3:16034.
